The Classification and Diagnosis of Headache Disorders

Edited by Jes Olesen

Frontiers in Headache Research Series

Gives insight into important new developments in headache diagnosis and explains the complex new classification system ICHD-2
Edited by the chairman of the Headache Classification Committee
An aid to clinical diagnosis in a complex field
Provides background for clinical, diagnostic decision making
Expert authors for every chapter

The Classification and Diagnosis of Headache Disorders

Edited by Jes Olesen

Frontiers in Headache Research Series

Description

The new international classification of headache disorders (IHCD-2) contains precise diagnostic criteria for headache disorders, but it is very difficult to read. The book, edited by the chairman of the classification committee, provides an invaluable insight for all those who diagnose headache in their daily practice. This book follows the International Headache Classification, but expands on it by discussing the background of the various diagnoses, the pitfalls and the practical problems in interpretation, and thus provides a more comprehensive source for those diagnosing headache disorders. It discusses diagnostic instruments such as headache diaries, headache calendars, and structured interviews. It also focuses on weak points in the headache classification where solid data is missing, and personal experience plays a greater role. Finally, it provides an insight for future descriptive research. A whole catalogue of research ideas are presented which can be realized in any clinical setting where a large number of headache patients are being treated.

The Classification and Diagnosis of Headache Disorders

Edited by Jes Olesen

Frontiers in Headache Research Series

Session I
Principles and Tools
1. Migraine with and without allodynia: New sub-classification of migraine, Rami Burstein and Moshe Jakubowski
2. The international classification of headache disorders 2nd edition (ICHD-2) and the 10th international classification of diseases, neurological adaptation (ICD10NA) classification of headache disorders, Jes Olesen
3. Principles and tools, Rigmor Jensen and Lars Bendtsen
4. Comparison of a pharmacy-based observational study with GCP-conform clinical studies with effervescent acetylsalicylic acid in migraine, Marianne Petersen-Braun, Ulrike Weingärtner, Uwer Gessner and Hartmut Göbel
5. Diagnostic criteria for primary headaches of ICHD 2nd edition 2004: Electronic clinical sheets ver. Int. W.2.O, Mauro Pedini, Andrea Alberti, Giovanni Mazzotta and Paola Sarchielli
6. Prevalence of migraine in the primary care setting, J Couch and Jayaseria Hettiarachchi
7. Prevalence, clinical characteristics and medication of migraine in Latin America: a population-based study, LE Morillo, LC Sanin, F Alarcón, N Aranaga, S Aulet, E Chapman, L Conterno, E Estévez, F Garcia-Pedroza, J Garrido, J Leston, M Macias-Islas, P Monzillo, L Núñez, A Perez, N Plascencia, C Rodriguez, F Silva, N Simonovis, Y Takeuchi, J Hettiarachchi
8. Discussion summary: principles and tools, R Lipton
Session II
The Primary Headaches Part I: The Migraines
9. The classification of migraine, RB Lipton and ME Bigal
10. Migraine with aura and its borderlands, M Kirchmann Eriksen, L Lykke Thomsen and J Olesen
11. Chronic migraine, NJ Wiendels and MD Ferrari
12. Appendix to the international classification of headache disorders (2nd edition): Application of diagnostic criteria for migraine without aura, P Torelli, E Beghi and GC Manzoni
13. Migraine with aura: IHS-subtypes 1988 compared to 2004 in clinical practice, H Göbel, A Heinze, K Heinze-Kuhn, U Todt and C Kubisch
14. ICHD-2 applied to 362 patients with migraine with aura according to the ICHD-1, MK Eriksen, LLThomsen and J Olesen
15. Validation of new diagnostic criteria (ICHD-2) for migraine with aura, MK Eriksen, LL Thomsen
Session III
The Primary Headaches - Part II
16. Tension-type headache - what is new in the 2nd edition of The International Classification of Headached Disorders?, L Bendtsen and R Jensen
17. Trigeminal autonomic cephalalgias, PJ Goadsby
18. Other primary headaches: Old concepts and new views, G Nappi, G Sandrini, N Ghiotto, AP Cecchini, C Tassorelli, G Sances
19. A case of hemicrania continua overlapping with other forms of strictly unilateral headaches associated with autonomic symptoms, G Nappi, C Tassoreli, G Sances, AP Cecchini, E Guaschino and G Sandrini
20. Appendix to the International Classification of Headache Disorders (2nd Edition): Application of diagnostic criteria for tension-type headache, P Torelli, E Beghi and GC Manzoni
21. Phenotype of chronic tension-type headache, H Göbel, A Heinze, K Heinze-Kuhn
22. Discussion summary: The primary headaches Part II, S Silberstein
Session IV
The Secondary Headaches - Part I
23. Headache attributed to infection, F Sakai
24. Headache attributed to cranial or cervical vascular disorder, M-G Bousser
25. Headache attributed to a stubstance or its withdrawal, SD Silberstein
26. Headache attributed to trauma, MJA Láinez
27. Duration of rebound headache in the treatment of substance-overuse headache: Effects of Prednisolone vs tricyclic antidepressants, H Göbel, A Heinze, K Heinze-Kuhn
28. Headache and spontaneous cervical artery dissections: Time-course and follow up, C Lucas, M Viallet, MA Mackowiak, M Girot, H Hénon and D Leys
29. Hyperhomocysteinemia due to MTHFR C677T polymorphism as a possible link between stroke and migraine in young population, P Marchione, P Giacomini, D Fortini, C Vento, D Samá, D Corigliano, G Nappi
30. Posttraumatic headache in patients with mild traumatic brain injury, Y Alekseenko and U Luchanok
31. Posttraumatic headache attributed to mild head injury, LJ Stovner, D Mickeviciene, H Schrader, D Obelieniene, D Surkiene, R Unickas and T Sand
32. Posttraumatic migraine secondary to organic lesions, AM Pascual, A Salvador, R Gil, MJA Láinez
33. Discussion summary: The secondary headaches - Part I, PJ Goadsby
Session V
The Secondary Headaches - Part II
34. Headache or facial pain attributed to disorder of cranium, neck, eyes, ears, nose, sinuses, teeth, mouth or other facial or cranial structures, H Göbel
35. Cranial neuralgias and central causes of facial pain, JW Lance
36. Headache diagnosis in systemic mastocytosis, S Ashina and M Ashina
37. Polycythemia: A cause of secondary headache?, AH Aamodt, A Waage and LJ Stovner
38. Discussion summary: The Secondary Headaches - Part II
Session VI
Practical Implementation and Research
39. Algorithms and simplified approaches to headache diagnosis, RB Lipton and ME Bigal
40. Application of ICHD 2nd edition criteria for primary headaches with the aid of a computerized structured medical record: some considerations, P Sarchielli, M Pedini, A Alberti, G Capocchi
41. French survey network on headaches and facial pains, M Lantéri-Minet, A Autret, G Baudesson, MG Bousser, C Creach, A Donent, V Dousset, N Fabre, G Girraud, E Guégan-Massardier, N Guy, C Lucas, H Massiou, G Mick, M Navez, A Pradalier, F Radat, D Valade, G Géraud
42. ID migraine TM: Validation and use of a three-item, self-administered questionnaire to identify migraine sufferers in a primary care population, RB Lipton, D Dodick, K Kolodner, J Hettiarachchi
43. The FRAMIG III survey. First epidemiological survey in general population according to the 2004 IHS migraine criteria, C Lucas, M Lanteri-Minet, MH Chautard
44. Discussion summary: Practical implementation and research, M Ashina

The Classification and Diagnosis of Headache Disorders

Edited by Jes Olesen

Frontiers in Headache Research Series

Author Information

Jes Olesen is Professor of Neurology, University of Copenhagen, Chairman of Danish Headache Center, Glostrup Hospital, University of Copenhagen, Denmark

Contributors:

F. Alarcón, Latin American Migraine Study Group; Andrea Alberti, Neuroscience Department, University of Perugia, Italy; N. Aranaga, Latin American Migraine Study Group; Messoud Ashina, Danish Headache Center and Department of Neurology, Glostrup Hospital, University of Copenhagen, Denmark; Sait Ashina, Danish Headache Center and Department of Neurology, Glostrup Hospital, University of Copenhagen, Denmark; S. Aulet, Latin American Migraine Study Group; A. Autret, Société Francaise d'Etudes Des Migraines et Céphalées (SFEMC); G. Baudesson, Société Francaise d'Etudes Des Migraines et Céphalées (SFEMC); E. Beghi, Mario Negri Institute and Neurological Clinic, University of Milano-Bicocca, Milan, Italy; Lars Bendtsen, The Danish Headache Center, Department of Neurology, University of Copenhagen, Glostrup Hospital, Denmark; Marcelo E. Bigal, Department of Neurology, Epidemiology and Population Health, Albert Einstein College of Medicine, and Montefiore Headache Clinic, New York, The New England Center for Headache, Stamford, USA; Marie-Germaine Bousser, Service de Neurologie, Hôpital Lariboisière, Paris, France; Rami Burstein, Department of Anesthesia and Critical Care, Harvard Institutes of Medicine, Boston, USA; Giuseppe Capocchi, Neurologic Clinic, Department of Neuroscience, University of Perugia, Italy; Alberto P. Cecchini, University Centre for Adaptive Disorders and Headache, IRCCS "C Mondino" Foundation, Pavia, Italy; E. Chapman, Latin American Migraine Study Group; M. H. Chautard, Astra Zeneca, France; L. Conterno, Latin American Migraine Study Group; Donatella Corigliano, Department of Neurology and Otholaringology, University of Rome La Sapienza, Italy; J. Couch, University of Oklahoma Health Sciences Center, Oklahoma City, USA; C. Creach, Société Francaise d'Etudes Des Migraines et Céphalées (SFEMC); D. Dodick, Mayo Clinic, Scottsdale, USA; A. Donnet, Société Francaise d'Etudes Des Migraines et Céphalées (SFEMC); V. Dousset, Société Francaise d'Etudes Des Migraines et Céphalées (SFEMC); Malene K. Eriksen, Danish Headache Center, University of Copenhagen, Department of Neurology, Glostrup University Hospital, Denmark; E. Estévez, Latin American Migraine Study Group; F. Fabre, Société Francaise d'Etudes Des Migraines et Céphalées (SFEMC); Michel D. Ferrari, Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands; Daniela Fortini, IRCCS S. Lucia, Rome, Italy; F. Garcia-Pedroza, Latin American Migraine Study Group; J. Garrido, Latin American Migraine Study Group; G. Géraud, Société Francaise d'Etudes Des Migraines et Céphalées (SFEMC); U. Gessner, Bayer Vital GmbH, Consumer-Care, Cologne, Germany; Natascia Ghiotto, University Centre for Adaptive Disorders and Headache, IRCCS "C Mondino" Foundation, Pavia, Itsly; Patrizia Giacomini, Department of Neurology and Otholaringology, University of Rome La Sapienza, Italy; Rosario Gil, Department of Neurology, Hospital Clinico Universitario, University of Valencia, Spain; G. Giraud, Société Francaise d'Etudes Des Migraines et Céphalées (SFEMC); M. Girot, Department of Neurology, Lille University Hospital, France; Peter J. Goadsby, Headache Group, Institute of Neurology, London, UK; Sances Grazia, University Centre for Adaptive Disorders and Headache, IRCCS "C Mondino" Foundation, Pavia, Italy; E. Guaschino, University Centre for Adaptive Disorders and Headache, IRCCS "C Mondino" Foundation, Pavia, Italy; E. Guégan-Massardier, Société Francaise d'Etudes Des Migraines et Céphalées (SFEMC); N. Guy, Société Francaise d'Etudes Des Migraines et Céphalées (SFEMC); Hartmut Göbel, Kiel Pain Clinic, Kiel, Germany; Axel Heinze, Kiel Pain Clinic, Kiel, Germany; Katja Heinze-Kuhn, Kiel Pain Clinic, Kiel, Germany; H. Hénon, Department of Neurology, Lille University Hospital, France; J. Hettiarachchi, Pfizer Inc, New York, USA; Moshe Jakubowski, Department of Anesthesia and Critical Care, Harvard Medical School, Boston, USA; Rigmor Jensen, The Danish Headache Center, Department of Neurology, University of Copenhagen, Glostrup Hospital, Denmark; K. Kolodnor, IMR, AdvancePCA, Hunt Valley, USA; Christian Kubisch, Institute of Human Genetics, University of Bonn, Germany; R. Kunickas, Traumatology Emergency Ward, Red Cross Hospital, Kaunas, Lithuania; Miguel J. A. Láinez, Department of Neurology, Hospital Clinico Universitaria, Valencia, Spain; James W. Lance, Institute of Neurological Sciences, Prince of Wales Hospital, Woollahra, Australia; M. Lanteri-Minet, Department of Evaluation and Treatment of Pain, Hopital Pasteur, Nice, France; J. Leston, Latin American Migraine Study Group; D. Leys, Department of Neurology, Lille University Hospital, France; Richard B. Lipton, Departments of Neurology, Epidemiology and Social Medicine, Albert Einstein College of Medicine, New York, USA; C. Lucas, Department of Neurology, Lille University Hospital, France; M. Macias-Islas, Latin American Migraine Study Group; M. A. Mackowiak, Department of Neurology, Lille University Hospital, France; G. C. Manzoni, Headache Center, Section of Neurology, Department of Neuroscience, University of Parma, Italy; Pasquale Marchione, Department of Neurology and Otholaringology, University of Rome La Sapienza, Italy; H. Massiou, Société Francaise d'Etudes Des Migraines et Céphalées (SFEMC); Giovanni Mazzotta, Neuroscience Department, University of Perugia, Italy; G. Mick, Société Francaise d'Etudes Des Migraines et Céphalées (SFEMC); D. Mickeviciene, Department of Neurology, Red Cross Hospital, Kaunas Lithuania and Department of Neurology, Medical University Clinic, Kaunas, Lithuania; P. Monzillo, Latin American Migraine Study Group; L. E. Morillo, Javeriana University, Bogotá, Colombia; Giuseppe Nappi, University Centre for Adaptive Disorders and Headache, IRCCS "C Mondino" Foundation, Pavia and Department of Neurology and Otolaryngology, University La Sapienza, Rome, Italy; M. Navez, Société Francaise d'Etudes Des Migraines et Céphalées (SFEMC); L. Núnez, Latin American Migraine Study Group; D. Obelieniene, Department of Neurology, Medical University Clinic, Kaunas, Lithuania; Jes Olesen, Department of Neurology, Glostrup Hospital, University of Copenhagen, Denmark; Ana M. Pascual, Department of Neurology, Hospital Clinico Universitario, University of Valencia, Spain; Mauro Pedini, Computer Science Educational Laboratory, Faculty of Medicine, Neurologic Clinic, University of Perugia, Italy; A. Perez, Latin American Migraine Study Group; M. Petersen-Braun, Bayer Vital GmbH, Consumer-Care, Cologne, Germany; N. Plascencia, Latin American Migraine Study Group; A. Pradalier, Société Francaise d'Etudes Des Migraines et Céphalées (SFEMC); F. Radat, Société Francaise d'Etudes Des Migraines et Céphalées (SFEMC); C. Rodriguez, Latin American Migraine Study Group; Fumihiko Sakai, Kitasato University Hospital, Sagamihara Kanagawa, Japan; Antonio Salvador, Department of Neurology, Hospital Clinico Universitario, University of Valencia, Spain; Domenico Samá, Department of Neurology and Otholaringology, University of Rome La Sapienza, Italy; T. Sand, Norwegian National Headache Center, Trondheim University Hospital, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Giorgio Sandrini, University Centre for Adaptive Disorders and Headache, IRCCS "C Mondino" Foundation, Pavia, Italy; L. C. Sanin, Latin American Migraine Study Group; Paola Sarchielli, Neurologic Clinic, Neuroscience Department, University of Perugia, Italy; H. Schrader, Norwegian National Headache Center, Trondheim University Hospital, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Stephen Silberstein, Director, Jefferson Headache Center and Professor of Neurology, Thomas Jefferson University Hospital, Philadelphia, USA; F. Silva, Latin American Migraine Study Group; N. Simonovis, Latin American Migraine Study Group; L. J. Stovner, Norwegian National Headache Center, Trondheim University Hospital, Faculty of Medicine, Norwegian University of Science and Technology, Norway; D. Surkiene, Department of Neurology, Medical University Clinic, Kaunas, Lithuania; Y. Takeuchi, Latin American Migraine Study Group; Cristina Tassorelli, University Centre for Adaptive Disorders and Headache, IRCCS "C Mondino" Foundation, Pavia, Italy; Lise Lykke, Thomsen,Danish Headache Center, University of Copenhagen, Department of Neurology, Glostrup, University Hospital, Denmark; Unda Todt, Institute of Human Genetics, University of Bonn, Germany; P. Torelli, Headache Center, Section of Neurology, Department of Neuroscience, University of Parma, Italy; D. Valade, Société Francaise d'Etudes Des Migraines et Céphalées (SFEMC); Claudio Vento, Department of Neurology and Otholaringology, University of Rome La Sapienza, Italy; M. Viallet, Department of Neurology, Lille University Hospital, France; U. Weingärtner, Bayer Vital GmbH, Consumer-Care, Cologne, Germany; Natalie J. Wiendels, Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands; A. Waage, Department of Medicine, Section for Hematology, Trondheim University Hospital, Norwegian University of Science and Technology, Norway; A. H. Aamodt, Norwegian National Headache Centre, Trondheim University Hospital, Norwegian University of Science and Technology, Norway.